title: Reversible posterior leukoencephalopathy syndrome and bevacizumab.
authors.forename: Peter
authors.initials: P
authors.lastname: Glusker
authors.forename: Larry
authors.initials: L
authors.lastname: Recht
authors.forename: Barton
authors.initials: B
authors.lastname: Lane
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D001921:Brain / Q000473:pathology; D005260:Female; D006801:Humans; D020343:Hypertensive Encephalopathy / Q000139:chemically induced* / Q000473:pathology; D007680:Kidney Neoplasms / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab